Quipt Home Medical Receives Buyout Proposal from Forager Capital at 120% Premium
PorAinvest
lunes, 25 de agosto de 2025, 9:10 am ET1 min de lectura
QIPT--
Quipt Home Medical, which provides durable and home medical equipment and supplies in the United States, has seen its target price lifted by Canaccord Genuity Group from $1.70 to $2.30 [1]. The company has a consensus rating of "Moderate Buy" and an average target price of $3.15 among analysts [1].
Forager Capital, which holds 9.7% of Quipt Home Medical, submitted a fully financed proposal to acquire all outstanding shares for $3.10 per share [4]. The proposal includes a go-shop provision, allowing the board to seek superior offers after signing the deal. Forager believes its Acquisition Proposal delivers immediate and certain value to all shareholders [4].
The acquisition proposal is not subject to financing or due diligence and can be executed immediately [2]. Quipt Home Medical's shares have seen significant institutional interest, with large investors such as Geode Capital Management LLC, Wells Fargo & Company MN, and Northern Trust Corp increasing their stakes in the company [1].
References:
[1] https://www.marketbeat.com/instant-alerts/quipt-home-medical-nasdaqqipt-price-target-raised-to-230-at-canaccord-genuity-group-2025-08-19/
[2] https://seekingalpha.com/news/4488726-forager-capital-proposes-buyout-of-quipt-home-medical-shares-up-22
[3] https://www.marketscreener.com/news/quipt-home-medical-shareholder-forager-capital-makes-another-buyout-bid-ce7c50d8d88ef022
[4] https://www.nasdaq.com/press-release/forager-capital-management-submits-fully-financed-proposal-acquire-quipt-home-medical
Forager Capital has proposed a buyout of Quipt Home Medical, offering $3.10 per share in cash, a 120% premium over the company's unaffected price of $1.41 as of May 19. The offer represents a 22% increase in Quipt's shares, and the proposal is not subject to due diligence.
Forager Capital has proposed a buyout of Quipt Home Medical (NASDAQ: QIPT), offering $3.10 per share in cash. This represents a 120% premium over the company's unaffected price of $1.41 as of May 19, 2025 [2]. The offer, which is not subject to due diligence, has led to a 22% increase in Quipt's shares, with shares trading up to $2.15 on Tuesday [1].Quipt Home Medical, which provides durable and home medical equipment and supplies in the United States, has seen its target price lifted by Canaccord Genuity Group from $1.70 to $2.30 [1]. The company has a consensus rating of "Moderate Buy" and an average target price of $3.15 among analysts [1].
Forager Capital, which holds 9.7% of Quipt Home Medical, submitted a fully financed proposal to acquire all outstanding shares for $3.10 per share [4]. The proposal includes a go-shop provision, allowing the board to seek superior offers after signing the deal. Forager believes its Acquisition Proposal delivers immediate and certain value to all shareholders [4].
The acquisition proposal is not subject to financing or due diligence and can be executed immediately [2]. Quipt Home Medical's shares have seen significant institutional interest, with large investors such as Geode Capital Management LLC, Wells Fargo & Company MN, and Northern Trust Corp increasing their stakes in the company [1].
References:
[1] https://www.marketbeat.com/instant-alerts/quipt-home-medical-nasdaqqipt-price-target-raised-to-230-at-canaccord-genuity-group-2025-08-19/
[2] https://seekingalpha.com/news/4488726-forager-capital-proposes-buyout-of-quipt-home-medical-shares-up-22
[3] https://www.marketscreener.com/news/quipt-home-medical-shareholder-forager-capital-makes-another-buyout-bid-ce7c50d8d88ef022
[4] https://www.nasdaq.com/press-release/forager-capital-management-submits-fully-financed-proposal-acquire-quipt-home-medical

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios